| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.07 |